Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT05014178

Kidney Sodium Functional Imaging

Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2025-02-12

200

Participants Needed

1

Research Sites

232 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The corticomedullary gradient is largely responsible for developing the gradients that are needed to concentrate urine (more solutes and less water). The ability of the kidneys to produce concentrated urine is a major determinant of the ability to survive the warm weather. When temperatures are high, we lose water through sweat, and so the kidneys retain water to maintain fluidity in the blood. The maintenance of a sodium (salt) gradient is required for urine concentration because increased medullary sodium concentration increases the reabsorption of water into the kidney, to be redistributed in the blood. The purpose of this study is to know if the corticomedullary gradient is altered in patients across a wide spectrum of kidney disease using sodium Magnetic Resonance Imaging (MRI), a machine that takes pictures and measures the salt content in the kidneys. 23Na kidney MRI, will provide functional MR of the kidney as a non-invasive tool to describe medullary function to improve management of chronic and kidney disease.

CONDITIONS

Official Title

Kidney Sodium Functional Imaging

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Healthy controls must have no kidney disease, heart failure, liver cirrhosis, or peripheral edema
  • CKD stages 1-5 with estimated GFR less than 90 mL/min/1.73m²
  • Patients on maintenance hemodialysis or peritoneal dialysis for more than 3 months
Not Eligible

You will not qualify if you...

  • Pregnant, breastfeeding, or planning pregnancy
  • Contraindications to MRI
  • Unable to tolerate MRI due to size or claustrophobia
  • Presence of implanted mechanical, electrical, or magnetic devices or metal in the body that cannot be removed, including pacemakers, neurostimulators, insulin pumps, aneurysm clips, bioprosthesis, artificial limbs, metallic fragments, tattoos, shunts, surgical staples, or ear implants

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Victoria Hospital, London Health Sciences Centre

London, Ontario, Canada, N6A 5W9

Actively Recruiting

Loading map...

Research Team

C

Christopher W McIntyre, MD

CONTACT

S

Sandrine Lemoine, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here